Improving CRISPR-Cas9 Screens in CAR T Cells: A Refined Method for Library Preparation

Area of Science:

• Immunotherapy
• Gene editing
• Cancer research

Background:

• Chimeric antigen receptor (CAR) T cell therapy shows promise in hematological cancers but faces challenges in solid tumors and relapse.
• Identifying genetic regulators of CAR T cell function is crucial for improving therapy persistence and overcoming resistance.
• Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 screening is a powerful tool for systematic gene discovery in cellular functions.

Purpose of the Study:

• To optimize a CRISPR-Cas9 knockout screening protocol for primary human CAR T cells.
• To improve the efficiency of single guide RNA (sgRNA) retrieval during screening library preparation.
• To enable the identification of genetic determinants that enhance CAR T cell efficacy and persistence.

Main Methods:

• Development of an optimized CRISPR-Cas9 screening protocol for primary human CAR T cells.
• Incorporation of an intermediate step involving enzymatic digestion and selective pulldown of sgRNA cassettes to reduce genomic DNA (gDNA) carryover.
• Testing the protocol's efficiency in retrieving sgRNA information from CAR T cell screens.

Main Results:

• The optimized protocol significantly improved the efficiency of the first PCR amplification step.
• Successful retrieval of sgRNA information was achieved, which was previously elusive with traditional PCR methods.
• The modified workflow demonstrated effectiveness in challenging samples like primary human CAR T cells.

Conclusions:

• The optimized CRISPR-Cas9 screening workflow facilitates library preparation in difficult samples.
• This improved method enables the identification of key genetic targets to enhance CAR T cell therapy.
• The findings contribute to advancing CAR T cell efficacy for both hematological and solid tumors.